skip navigation
A B C D E F G H I J K L M N O P Q

Test Identifier Information

 
Registration CodeEMAB
Method

Flow cytometry method which quantitates the fluorescence intensity as mean channel fluorescence (MCF) of intact red cells after incubation with eosin-5'-maleimide (EMA)

Diagnostic Use / Indications

Used as a screening test to detect structual defects in the red cell membrane associated with Hereditary Spherocytosis.

refer to the following two documents:

Screening Tests for Hereditary Spherocytosis

Guidelines for Diagnosis of Hereditary Spherocytosis

 

External Price$237.53(Exclusive of GST)
  

Specimen Collection

 
Pre-Testing Requirements

Please contact laboratory to arrange suitable day and time for testing, courier transportation and notification to Waikato Hospital. Blood sample must be collected prior to any blood transfusion or at least 60 days from any previous blood transfusion.

Patient Specimen4.0mL EDTA (Lavender)
Paediatric Specimen1.0mL EDTA (Lavender)
Sample Delivery to Labsample kept at 4C as soon as possible after collection
  

CHLabs Laboratory

 
DepartmentHaematology - Special Tests
Contact Details Email Email
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Contact Phone Number(03) 364 0373 | x80373
Test Availabilitycontact laboratory
Turnaround Time3 days
Referred toHaematology laboratory, Waikato Hospital
Reference Interval

A mean channel fluorescence below the cutoff value of 45.5 is consistent with a diagnosis of Hereditary Spherocytosis.

Interpretation

Results of the EMA binding test should be interpreted in conjunction with clinical information, red cell indices and blood film findings.

 

Delphic Number Test Number8284

CHL Follow us on Facebook